Clinical Trial Detail

NCT ID NCT01305213
Title Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

peritoneal carcinoma

fallopian tube cancer

ovarian cancer

Therapies

Fosbretabulin

Bevacizumab

Age Groups: senior adult

No variant requirements are available.